Skip to content

Clinical trials

Phase 1/2 Metabolic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Phase 1/2 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20071
20091
20121
20131
20141
20151
20161
20171
20191
20201
20212
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed5
Terminated5
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.2
Washington University School of Medicine2
4D Molecular Therapeutics1
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Baylor College of Medicine1
Diva De Leon1
Eledon Pharmaceuticals1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Forge Biologics, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases20
Genetic Diseases, Inborn7
Metabolism, Inborn Errors6
Lysosomal Storage Diseases4
Brain Diseases, Metabolic3
Hypoglycemia3
Immune System Diseases3
Acid-Base Imbalance2
Acidosis2
Amino Acid Metabolism, Inborn Errors2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.